Bayer faces appeals of IP Australia rulings on antiseptic patent
Agriculture 2019-06-04 3:24 pm By Miklos Bolza | Sydney
Please login to bookmark Close

Veterinary pharmaceutical companies Norbrook Laboratories and Merial have launched twin appeals of two IP Australia decisions allowing Bayer to amend a proposed patent for a treatment for mammary gland infections.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au